Form 8-K - Current report:
SEC Accession No. 0000950170-25-053745
Filing Date
2025-04-14
Accepted
2025-04-14 16:45:08
Documents
14
Period of Report
2025-04-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hcwb-20250414.htm   iXBRL 8-K 46461
2 EX-5.1 hcwb-ex5_1.htm EX-5.1 26166
3 GRAPHIC img199955712_0.jpg GRAPHIC 11939
4 GRAPHIC img199955712_1.jpg GRAPHIC 3543
  Complete submission text file 0000950170-25-053745.txt   214373

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hcwb-20250414.xsd EX-101.SCH 24849
16 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20250414_htm.xml XML 4700
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

EIN.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40591 | Film No.: 25836504
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)